Navigation Links
Patients Receiving Treatment with Radiotherapy Might trigger Security Alarms

A team of doctors, in their article in the British Medical Journal, said patients needed to be warned on the possibility of setting off// the alarms in airports even after many weeks of their treatment.

Radiation treatment is frequently used to treat cancers and thyroid conditions. This warning by the doctors had come following the case where a 46-year-old man had set off alarms at Orlando airport in Florida six weeks after his treatment. It was reported that the person was detained, strip-searched and sniffer dogs brought in before he was ultimately allowed continue on his journey.

It was explained that man had been treated for a thyroid condition, known a s thyrotoxicosis, with radioiodine. Statistics have shown that almost around 10,000 patients in the UK receive such treatment every year for thyroid problems. Experts have explained that radioisotopes are also used for treatment of conditions of the heart, bone, and iodine uptake scans, and that it lasts in the system for a few days.

A team of researchers from City Hospital in Birmingham have said that doctors had to take more steps in explaining to the patients, making them aware that they were radioactive for almost up to 95 days after treatment. They had also quoted a further four examples where people had triggered alarms, which also included two patients who had entered the White House on a public tour and a man who triggered the security alarm at his bank. Dr Kalyan Kumar Gangopadhyay said, “Security alarms have been made more sensitive and people are going to come across these problems more and more.” The doctors had concluded that this practical advice would have to be included into the new guidelines on the use of radioiodine for thyroid disease, which are to be published by the Royal College of Physicians, later in the year.

'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
Other Medicine News:Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 2Health News:Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation 3Health News:'That's My Hope' Audio Edition Released 2Health News:'That's My Hope' Audio Edition Released 3Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 2Health News:Saint Francis Medical Center Physician Services Implements MED3OOO RCM and ASP Services 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 2Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 3Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 4Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 5Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 6Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 7Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 8Health News:NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results 9Health News:AND Calls on DoD to Open All Military Units to Women, Grant Parental Leave to Service Members 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 2Health News:Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference 3
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Fresh Blood Boosts Survival in Trauma Patients 58799 1Fresh Blood Boosts Survival in Trauma Patients 58799 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 1Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 2Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 3Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 4Preventing Injuries In Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews M D and Athletes 26apos 3B Performance 58796 5Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 1Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 2Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 3Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 4Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera 28TM 29 for Gaucher Disease 58793 5